Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
KCNK4
REST API REST API
Homo sapiens
KCNK4 is differentially expressed in 104 experiments: 41 organism parts: cervix, ovary, ... (39 more);, 44 disease states: normal, Huntington's disease, ... (42 more);, 40 cell types 85 cell lines 8 compound treatments and 40 other conditions.
Synonyms TRAAK, K2p4.1
Orthologs KCNK4 (Danio rerio)   Kcnk4 (Mus musculus)   KCNK4 (Bos taurus)   ENSCING00000005467 (Ciona intestinalis)   Kcnk4 (Rattus norvegicus)   CG34396 (Drosophila melanogaster)   kcnk4 (Xenopus laevis)   KCNK4 (Canis familiaris)   CG43155 (Drosophila melanogaster)   (Compare orthologs)
Gene Ontology Term plasma membrane, ion transport, membrane, ion channel activity, potassium ion transport, synaptic transmission, voltage-gated ion channel activity, potassium channel activity, integral to membrane, transmembrane transport, potassium ion transmembrane transport
InterPro Term K_chnl_2pore, Ion_trans_2, K_chnl_2pore_TASK, Ion_trans, K_chnl_2pore_TRAAK, K_chnl_2pore_TREK
UniProt Accession Q9NYG8, F5GYE0, F5GZ20
Search EB-eye ENSG00000182450
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-GEOD-803, E-GEOD-6573, E-GEOD-18105, E-AFMX-6, ... (9 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, E-GEOD-20854, ... (17 experiments)

Factor Value U/D Experiments
DU145
2
E-GEOD-17482, E-GEOD-20089
MCF-7
1
2
E-GEOD-19639, E-GEOD-20081, E-GEOD-5823
CCRFCEM
1
E-GEOD-24147
TT
1
E-MTAB-37
NCIH1838
1
E-MTAB-37
CAL62
1
E-MTAB-37
79 more value(s).


Cell type

studied in E-GEOD-15893, E-GEOD-18811, E-GEOD-22373, E-GEOD-21668, E-GEOD-20033, ... (23 experiments)

Factor Value U/D Experiments
human embryonic stem cell
1
E-GEOD-18265
CD326negCD56+ cell
1
E-GEOD-21668
CD34 positive
1
E-GEOD-12662
ovarian cancer
1
E-GEOD-21154
CD34+ hematopoietic progenitor cell
1
E-GEOD-19240
endothelial cell
1
E-GEOD-19240
34 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-MEXP-2069, E-GEOD-9692, ... (25 experiments)

Factor Value U/D Experiments
acute HIV-1 infection
1
E-GEOD-16363
colorectal adenocarcinoma
1
E-MTAB-37
liver carcinoma
1
E-MTAB-37
hypertrophic cardiomyopathy
1
E-GEOD-1145
control
1
E-GEOD-8121
breast carcinoma
1
E-TABM-276
38 more value(s).


Compound treatment

studied in E-TABM-868, E-GEOD-5099, E-GEOD-7307, E-GEOD-20081, E-MEXP-2645 ... (5 experiments)

Factor Value U/D Experiments
none
2
E-GEOD-7307, E-TABM-868
lipopolysaccharide
4
1
E-TABM-868
Cxcl12
1
E-GEOD-7307
estradiol
1
E-GEOD-20081
interferon-gamma + lipopolysaccharide
1
1
E-GEOD-5099
Cxcr4
1
E-GEOD-7307
2 more value(s).


Age at diagnosis

studied in E-GEOD-4922

Factor Value U/D Experiments
38 years
1
E-GEOD-4922


Biosource provider
studied in E-TABM-325

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-21138

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023

Genotype
studied in E-GEOD-22056, E-GEOD-17476, E-MEXP-1838

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-MEXP-2657, E-GEOD-20540, E-GEOD-9764

Histology
studied in E-TABM-234, E-GEOD-21653

Individual
studied in E-MTAB-197, E-MEXP-1290, E-MEXP-2069, E-TABM-666, E-GEOD-19519, ... (13 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19246

pt
studied in E-GEOD-21653

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Stimulation
studied in E-GEOD-20114

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Treatment
studied in E-GEOD-16837

Tumor grading
studied in E-GEOD-4290

Processing time: 0.475 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM